Home524816 • BOM
add
Natco Pharma Ltd.
Previous close
₹1,389.35
Day range
₹1,364.80 - ₹1,403.00
Year range
₹725.00 - ₹1,638.35
Market cap
250.57B INR
Avg Volume
53.76K
P/E ratio
15.33
Dividend yield
0.39%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 13.63B | 19.47% |
Operating expense | 4.22B | 3.11% |
Net income | 6.68B | 59.05% |
Net profit margin | 49.06 | 33.13% |
Earnings per share | 37.32 | 60.45% |
EBITDA | 8.07B | 40.06% |
Effective tax rate | 16.81% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.49B | 59.13% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 58.53B | — |
Shares outstanding | 179.13M | — |
Price to book | 4.25 | — |
Return on assets | — | — |
Return on capital | 30.55% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 6.68B | 59.05% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad with a presence in formulation and active pharmaceutical ingredients in both domestic and international markets. The company also manufactures Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. The company has a presence in 50+ countries. NATCO is a science driven company and focuses on limited competition molecules in the US .The company’s pharma division has 5 manufacturing facilities, 2 API and intermediate manufacturing facilities and the crop health sciences division has one formulation and one technical manufacturing facility. The company boasts of having a talent pool of 450+ scientists working out of two research centers in India.
Across the globe, cancer treatment saw a sea change in early 2000s in terms of screening, diagnosis, molecular pathology, targeted therapies, immunotherapies, Bone Marrow Transplants, and supportive care. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016